for Journals by Title or ISSN
for Articles by Keywords
help

Publisher: Elsevier   (Total: 3123 journals)

 A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 3 4 5 6 7 8 | Last   [Sort by number of followers]   [Restore default list]

Showing 1 - 200 of 3120 Journals sorted alphabetically
A Practical Logic of Cognitive Systems     Full-text available via subscription   (Followers: 8)
AASRI Procedia     Open Access   (Followers: 15)
Academic Pediatrics     Hybrid Journal   (Followers: 26, SJR: 1.402, h-index: 51)
Academic Radiology     Hybrid Journal   (Followers: 22, SJR: 1.008, h-index: 75)
Accident Analysis & Prevention     Partially Free   (Followers: 90, SJR: 1.109, h-index: 94)
Accounting Forum     Hybrid Journal   (Followers: 25, SJR: 0.612, h-index: 27)
Accounting, Organizations and Society     Hybrid Journal   (Followers: 30, SJR: 2.515, h-index: 90)
Achievements in the Life Sciences     Open Access   (Followers: 4)
Acta Anaesthesiologica Taiwanica     Open Access   (Followers: 5, SJR: 0.338, h-index: 19)
Acta Astronautica     Hybrid Journal   (Followers: 378, SJR: 0.726, h-index: 43)
Acta Automatica Sinica     Full-text available via subscription   (Followers: 3)
Acta Biomaterialia     Hybrid Journal   (Followers: 26, SJR: 2.02, h-index: 104)
Acta Colombiana de Cuidado Intensivo     Full-text available via subscription   (Followers: 1)
Acta de Investigación Psicológica     Open Access   (Followers: 2)
Acta Ecologica Sinica     Open Access   (Followers: 8, SJR: 0.172, h-index: 29)
Acta Haematologica Polonica     Free   (Followers: 1, SJR: 0.123, h-index: 8)
Acta Histochemica     Hybrid Journal   (Followers: 3, SJR: 0.604, h-index: 38)
Acta Materialia     Hybrid Journal   (Followers: 237, SJR: 3.683, h-index: 202)
Acta Mathematica Scientia     Full-text available via subscription   (Followers: 5, SJR: 0.615, h-index: 21)
Acta Mechanica Solida Sinica     Full-text available via subscription   (Followers: 9, SJR: 0.442, h-index: 21)
Acta Oecologica     Hybrid Journal   (Followers: 10, SJR: 0.915, h-index: 53)
Acta Otorrinolaringologica (English Edition)     Full-text available via subscription   (Followers: 1)
Acta Otorrinolaringológica Española     Full-text available via subscription   (Followers: 3, SJR: 0.311, h-index: 16)
Acta Pharmaceutica Sinica B     Open Access   (Followers: 2)
Acta Poética     Open Access   (Followers: 4)
Acta Psychologica     Hybrid Journal   (Followers: 25, SJR: 1.365, h-index: 73)
Acta Sociológica     Open Access  
Acta Tropica     Hybrid Journal   (Followers: 6, SJR: 1.059, h-index: 77)
Acta Urológica Portuguesa     Open Access  
Actas Dermo-Sifiliograficas     Full-text available via subscription   (Followers: 4)
Actas Dermo-Sifiliográficas (English Edition)     Full-text available via subscription   (Followers: 3)
Actas Urológicas Españolas     Full-text available via subscription   (Followers: 4, SJR: 0.383, h-index: 19)
Actas Urológicas Españolas (English Edition)     Full-text available via subscription   (Followers: 2)
Actualites Pharmaceutiques     Full-text available via subscription   (Followers: 5, SJR: 0.141, h-index: 3)
Actualites Pharmaceutiques Hospitalieres     Full-text available via subscription   (Followers: 4, SJR: 0.112, h-index: 2)
Acupuncture and Related Therapies     Hybrid Journal   (Followers: 5)
Acute Pain     Full-text available via subscription   (Followers: 13)
Ad Hoc Networks     Hybrid Journal   (Followers: 11, SJR: 0.967, h-index: 57)
Addictive Behaviors     Hybrid Journal   (Followers: 15, SJR: 1.514, h-index: 92)
Addictive Behaviors Reports     Open Access   (Followers: 7)
Additive Manufacturing     Hybrid Journal   (Followers: 7, SJR: 1.039, h-index: 5)
Additives for Polymers     Full-text available via subscription   (Followers: 22)
Advanced Cement Based Materials     Full-text available via subscription   (Followers: 3)
Advanced Drug Delivery Reviews     Hybrid Journal   (Followers: 140, SJR: 5.2, h-index: 222)
Advanced Engineering Informatics     Hybrid Journal   (Followers: 11, SJR: 1.265, h-index: 53)
Advanced Powder Technology     Hybrid Journal   (Followers: 17, SJR: 0.739, h-index: 33)
Advances in Accounting     Hybrid Journal   (Followers: 9, SJR: 0.299, h-index: 15)
Advances in Agronomy     Full-text available via subscription   (Followers: 15, SJR: 2.071, h-index: 82)
Advances in Anesthesia     Full-text available via subscription   (Followers: 27, SJR: 0.169, h-index: 4)
Advances in Antiviral Drug Design     Full-text available via subscription   (Followers: 4)
Advances in Applied Mathematics     Full-text available via subscription   (Followers: 9, SJR: 1.054, h-index: 35)
Advances in Applied Mechanics     Full-text available via subscription   (Followers: 12, SJR: 0.801, h-index: 26)
Advances in Applied Microbiology     Full-text available via subscription   (Followers: 23, SJR: 1.286, h-index: 49)
Advances In Atomic, Molecular, and Optical Physics     Full-text available via subscription   (Followers: 16, SJR: 3.31, h-index: 42)
Advances in Biological Regulation     Hybrid Journal   (Followers: 4, SJR: 2.277, h-index: 43)
Advances in Botanical Research     Full-text available via subscription   (Followers: 3, SJR: 0.619, h-index: 48)
Advances in Cancer Research     Full-text available via subscription   (Followers: 26, SJR: 2.215, h-index: 78)
Advances in Carbohydrate Chemistry and Biochemistry     Full-text available via subscription   (Followers: 9, SJR: 0.9, h-index: 30)
Advances in Catalysis     Full-text available via subscription   (Followers: 6, SJR: 2.139, h-index: 42)
Advances in Cell Aging and Gerontology     Full-text available via subscription   (Followers: 4)
Advances in Cellular and Molecular Biology of Membranes and Organelles     Full-text available via subscription   (Followers: 13)
Advances in Chemical Engineering     Full-text available via subscription   (Followers: 26, SJR: 0.183, h-index: 23)
Advances in Child Development and Behavior     Full-text available via subscription   (Followers: 10, SJR: 0.665, h-index: 29)
Advances in Chronic Kidney Disease     Full-text available via subscription   (Followers: 9, SJR: 1.268, h-index: 45)
Advances in Clinical Chemistry     Full-text available via subscription   (Followers: 29, SJR: 0.938, h-index: 33)
Advances in Colloid and Interface Science     Full-text available via subscription   (Followers: 18, SJR: 2.314, h-index: 130)
Advances in Computers     Full-text available via subscription   (Followers: 16, SJR: 0.223, h-index: 22)
Advances in Dermatology     Full-text available via subscription   (Followers: 12)
Advances in Developmental Biology     Full-text available via subscription   (Followers: 12)
Advances in Digestive Medicine     Open Access   (Followers: 7)
Advances in DNA Sequence-Specific Agents     Full-text available via subscription   (Followers: 6)
Advances in Drug Research     Full-text available via subscription   (Followers: 23)
Advances in Ecological Research     Full-text available via subscription   (Followers: 47, SJR: 3.25, h-index: 43)
Advances in Engineering Software     Hybrid Journal   (Followers: 27, SJR: 0.486, h-index: 10)
Advances in Experimental Biology     Full-text available via subscription   (Followers: 9)
Advances in Experimental Social Psychology     Full-text available via subscription   (Followers: 46, SJR: 5.465, h-index: 64)
Advances in Exploration Geophysics     Full-text available via subscription   (Followers: 3)
Advances in Food and Nutrition Research     Full-text available via subscription   (Followers: 52, SJR: 0.674, h-index: 38)
Advances in Fuel Cells     Full-text available via subscription   (Followers: 16)
Advances in Genetics     Full-text available via subscription   (Followers: 17, SJR: 2.558, h-index: 54)
Advances in Genome Biology     Full-text available via subscription   (Followers: 11)
Advances in Geophysics     Full-text available via subscription   (Followers: 6, SJR: 2.325, h-index: 20)
Advances in Heat Transfer     Full-text available via subscription   (Followers: 22, SJR: 0.906, h-index: 24)
Advances in Heterocyclic Chemistry     Full-text available via subscription   (Followers: 9, SJR: 0.497, h-index: 31)
Advances in Human Factors/Ergonomics     Full-text available via subscription   (Followers: 27)
Advances in Imaging and Electron Physics     Full-text available via subscription   (Followers: 2, SJR: 0.396, h-index: 27)
Advances in Immunology     Full-text available via subscription   (Followers: 36, SJR: 4.152, h-index: 85)
Advances in Inorganic Chemistry     Full-text available via subscription   (Followers: 9, SJR: 1.132, h-index: 42)
Advances in Insect Physiology     Full-text available via subscription   (Followers: 3, SJR: 1.274, h-index: 27)
Advances in Integrative Medicine     Hybrid Journal   (Followers: 6)
Advances in Intl. Accounting     Full-text available via subscription   (Followers: 4)
Advances in Life Course Research     Hybrid Journal   (Followers: 8, SJR: 0.764, h-index: 15)
Advances in Lipobiology     Full-text available via subscription   (Followers: 2)
Advances in Magnetic and Optical Resonance     Full-text available via subscription   (Followers: 10)
Advances in Marine Biology     Full-text available via subscription   (Followers: 16, SJR: 1.645, h-index: 45)
Advances in Mathematics     Full-text available via subscription   (Followers: 10, SJR: 3.261, h-index: 65)
Advances in Medical Sciences     Hybrid Journal   (Followers: 6, SJR: 0.489, h-index: 25)
Advances in Medicinal Chemistry     Full-text available via subscription   (Followers: 6)
Advances in Microbial Physiology     Full-text available via subscription   (Followers: 5, SJR: 1.44, h-index: 51)
Advances in Molecular and Cell Biology     Full-text available via subscription   (Followers: 23)
Advances in Molecular and Cellular Endocrinology     Full-text available via subscription   (Followers: 10)
Advances in Molecular Toxicology     Full-text available via subscription   (Followers: 9, SJR: 0.324, h-index: 8)
Advances in Nanoporous Materials     Full-text available via subscription   (Followers: 4)
Advances in Oncobiology     Full-text available via subscription   (Followers: 2)
Advances in Organ Biology     Full-text available via subscription   (Followers: 2)
Advances in Organometallic Chemistry     Full-text available via subscription   (Followers: 15, SJR: 2.885, h-index: 45)
Advances in Parallel Computing     Full-text available via subscription   (Followers: 7, SJR: 0.148, h-index: 11)
Advances in Parasitology     Full-text available via subscription   (Followers: 7, SJR: 2.37, h-index: 73)
Advances in Pediatrics     Full-text available via subscription   (Followers: 24, SJR: 0.4, h-index: 28)
Advances in Pharmaceutical Sciences     Full-text available via subscription   (Followers: 13)
Advances in Pharmacology     Full-text available via subscription   (Followers: 16, SJR: 1.718, h-index: 58)
Advances in Physical Organic Chemistry     Full-text available via subscription   (Followers: 8, SJR: 0.384, h-index: 26)
Advances in Phytomedicine     Full-text available via subscription  
Advances in Planar Lipid Bilayers and Liposomes     Full-text available via subscription   (Followers: 3, SJR: 0.248, h-index: 11)
Advances in Plant Biochemistry and Molecular Biology     Full-text available via subscription   (Followers: 7)
Advances in Plant Pathology     Full-text available via subscription   (Followers: 5)
Advances in Porous Media     Full-text available via subscription   (Followers: 5)
Advances in Protein Chemistry     Full-text available via subscription   (Followers: 18)
Advances in Protein Chemistry and Structural Biology     Full-text available via subscription   (Followers: 20, SJR: 1.5, h-index: 62)
Advances in Quantum Chemistry     Full-text available via subscription   (Followers: 6, SJR: 0.478, h-index: 32)
Advances in Radiation Oncology     Open Access  
Advances in Small Animal Medicine and Surgery     Hybrid Journal   (Followers: 3, SJR: 0.1, h-index: 2)
Advances in Space Biology and Medicine     Full-text available via subscription   (Followers: 5)
Advances in Space Research     Full-text available via subscription   (Followers: 371, SJR: 0.606, h-index: 65)
Advances in Structural Biology     Full-text available via subscription   (Followers: 8)
Advances in Surgery     Full-text available via subscription   (Followers: 9, SJR: 0.823, h-index: 27)
Advances in the Study of Behavior     Full-text available via subscription   (Followers: 31, SJR: 1.321, h-index: 56)
Advances in Veterinary Medicine     Full-text available via subscription   (Followers: 16)
Advances in Veterinary Science and Comparative Medicine     Full-text available via subscription   (Followers: 13)
Advances in Virus Research     Full-text available via subscription   (Followers: 6, SJR: 1.878, h-index: 68)
Advances in Water Resources     Hybrid Journal   (Followers: 45, SJR: 2.408, h-index: 94)
Aeolian Research     Hybrid Journal   (Followers: 5, SJR: 0.973, h-index: 22)
Aerospace Science and Technology     Hybrid Journal   (Followers: 338, SJR: 0.816, h-index: 49)
AEU - Intl. J. of Electronics and Communications     Hybrid Journal   (Followers: 8, SJR: 0.318, h-index: 36)
African J. of Emergency Medicine     Open Access   (Followers: 6, SJR: 0.344, h-index: 6)
Ageing Research Reviews     Hybrid Journal   (Followers: 9, SJR: 3.289, h-index: 78)
Aggression and Violent Behavior     Hybrid Journal   (Followers: 433, SJR: 1.385, h-index: 72)
Agri Gene     Hybrid Journal  
Agricultural and Forest Meteorology     Hybrid Journal   (Followers: 15, SJR: 2.18, h-index: 116)
Agricultural Systems     Hybrid Journal   (Followers: 31, SJR: 1.275, h-index: 74)
Agricultural Water Management     Hybrid Journal   (Followers: 42, SJR: 1.546, h-index: 79)
Agriculture and Agricultural Science Procedia     Open Access  
Agriculture and Natural Resources     Open Access   (Followers: 3)
Agriculture, Ecosystems & Environment     Hybrid Journal   (Followers: 56, SJR: 1.879, h-index: 120)
Ain Shams Engineering J.     Open Access   (Followers: 5, SJR: 0.434, h-index: 14)
Air Medical J.     Hybrid Journal   (Followers: 5, SJR: 0.234, h-index: 18)
AKCE Intl. J. of Graphs and Combinatorics     Open Access   (SJR: 0.285, h-index: 3)
Alcohol     Hybrid Journal   (Followers: 11, SJR: 0.922, h-index: 66)
Alcoholism and Drug Addiction     Open Access   (Followers: 8)
Alergologia Polska : Polish J. of Allergology     Full-text available via subscription   (Followers: 1)
Alexandria Engineering J.     Open Access   (Followers: 1, SJR: 0.436, h-index: 12)
Alexandria J. of Medicine     Open Access   (Followers: 1)
Algal Research     Partially Free   (Followers: 9, SJR: 2.05, h-index: 20)
Alkaloids: Chemical and Biological Perspectives     Full-text available via subscription   (Followers: 3)
Allergologia et Immunopathologia     Full-text available via subscription   (Followers: 1, SJR: 0.46, h-index: 29)
Allergology Intl.     Open Access   (Followers: 4, SJR: 0.776, h-index: 35)
Alpha Omegan     Full-text available via subscription   (SJR: 0.121, h-index: 9)
ALTER - European J. of Disability Research / Revue Européenne de Recherche sur le Handicap     Full-text available via subscription   (Followers: 9, SJR: 0.158, h-index: 9)
Alzheimer's & Dementia     Hybrid Journal   (Followers: 49, SJR: 4.289, h-index: 64)
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring     Open Access   (Followers: 4)
Alzheimer's & Dementia: Translational Research & Clinical Interventions     Open Access   (Followers: 4)
Ambulatory Pediatrics     Hybrid Journal   (Followers: 5)
American Heart J.     Hybrid Journal   (Followers: 48, SJR: 3.157, h-index: 153)
American J. of Cardiology     Hybrid Journal   (Followers: 48, SJR: 2.063, h-index: 186)
American J. of Emergency Medicine     Hybrid Journal   (Followers: 42, SJR: 0.574, h-index: 65)
American J. of Geriatric Pharmacotherapy     Full-text available via subscription   (Followers: 9, SJR: 1.091, h-index: 45)
American J. of Geriatric Psychiatry     Hybrid Journal   (Followers: 14, SJR: 1.653, h-index: 93)
American J. of Human Genetics     Hybrid Journal   (Followers: 32, SJR: 8.769, h-index: 256)
American J. of Infection Control     Hybrid Journal   (Followers: 26, SJR: 1.259, h-index: 81)
American J. of Kidney Diseases     Hybrid Journal   (Followers: 31, SJR: 2.313, h-index: 172)
American J. of Medicine     Hybrid Journal   (Followers: 45, SJR: 2.023, h-index: 189)
American J. of Medicine Supplements     Full-text available via subscription   (Followers: 3)
American J. of Obstetrics and Gynecology     Hybrid Journal   (Followers: 207, SJR: 2.255, h-index: 171)
American J. of Ophthalmology     Hybrid Journal   (Followers: 61, SJR: 2.803, h-index: 148)
American J. of Ophthalmology Case Reports     Open Access   (Followers: 6)
American J. of Orthodontics and Dentofacial Orthopedics     Full-text available via subscription   (Followers: 6, SJR: 1.249, h-index: 88)
American J. of Otolaryngology     Hybrid Journal   (Followers: 24, SJR: 0.59, h-index: 45)
American J. of Pathology     Hybrid Journal   (Followers: 27, SJR: 2.653, h-index: 228)
American J. of Preventive Medicine     Hybrid Journal   (Followers: 26, SJR: 2.764, h-index: 154)
American J. of Surgery     Hybrid Journal   (Followers: 36, SJR: 1.286, h-index: 125)
American J. of the Medical Sciences     Hybrid Journal   (Followers: 12, SJR: 0.653, h-index: 70)
Ampersand : An Intl. J. of General and Applied Linguistics     Open Access   (Followers: 6)
Anaerobe     Hybrid Journal   (Followers: 4, SJR: 1.066, h-index: 51)
Anaesthesia & Intensive Care Medicine     Full-text available via subscription   (Followers: 60, SJR: 0.124, h-index: 9)
Anaesthesia Critical Care & Pain Medicine     Full-text available via subscription   (Followers: 14)
Anales de Cirugia Vascular     Full-text available via subscription  
Anales de Pediatría     Full-text available via subscription   (Followers: 2, SJR: 0.209, h-index: 27)
Anales de Pediatría (English Edition)     Full-text available via subscription  
Anales de Pediatría Continuada     Full-text available via subscription   (SJR: 0.104, h-index: 3)
Analytic Methods in Accident Research     Hybrid Journal   (Followers: 4, SJR: 2.577, h-index: 7)
Analytica Chimica Acta     Hybrid Journal   (Followers: 36, SJR: 1.548, h-index: 152)
Analytical Biochemistry     Hybrid Journal   (Followers: 173, SJR: 0.725, h-index: 154)
Analytical Chemistry Research     Open Access   (Followers: 8, SJR: 0.18, h-index: 2)
Analytical Spectroscopy Library     Full-text available via subscription   (Followers: 12)
Anesthésie & Réanimation     Full-text available via subscription   (Followers: 1)
Anesthesiology Clinics     Full-text available via subscription   (Followers: 22, SJR: 0.421, h-index: 40)
Angiología     Full-text available via subscription   (SJR: 0.124, h-index: 9)
Angiologia e Cirurgia Vascular     Open Access  
Animal Behaviour     Hybrid Journal   (Followers: 176, SJR: 1.907, h-index: 126)
Animal Feed Science and Technology     Hybrid Journal   (Followers: 5, SJR: 1.151, h-index: 83)

        1 2 3 4 5 6 7 8 | Last   [Sort by number of followers]   [Restore default list]

Journal Cover American Journal of Medicine
  [SJR: 2.023]   [H-I: 189]   [45 followers]  Follow
    
   Hybrid Journal Hybrid journal (It can contain Open Access articles)
   ISSN (Print) 0002-9343 - ISSN (Online) 1555-7162
   Published by Elsevier Homepage  [3123 journals]
  • Lights Out: An Unusual Case of Amaurosis Fugax
    • Authors: Mark R. Parsons; Michael C. Stoner; Adam Doyle; Doran Mix; Scott J. Cameron
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Mark R. Parsons, Michael C. Stoner, Adam Doyle, Doran Mix, Scott J. Cameron


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.08.032
       
  • The Midnight Bite! A Kissing Bug Nightmare
    • Authors: Norman L. Beatty; Stephen A. Klotz
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Norman L. Beatty, Stephen A. Klotz


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.013
       
  • Diffuse Esophageal Spasm: Corkscrew Esophagus
    • Authors: Hiroki Matsuura
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Hiroki Matsuura


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.08.041
       
  • Arteriovenous Fistula: An Uncommon Cause of Heart Failure
    • Authors: Abhilash Koratala; Freddy R. Malpartida; Mayanka Kamboj; Kawther F. Alquadan
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Abhilash Koratala, Freddy R. Malpartida, Mayanka Kamboj, Kawther F. Alquadan


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.08.028
       
  • Patient with Gluten Encephalopathy Presenting with Neuropsychiatric
           Symptoms
    • Authors: Iqra Arshad; Athar Javeed; Ubaid Ullah
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Iqra Arshad, Athar Javeed, Ubaid Ullah


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.09.023
       
  • Pulmonary Embolism Presenting as Persistent Hiccups
    • Authors: Munveer Thind; David A. Cohen
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Munveer Thind, David A. Cohen


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.08.030
       
  • Rare Complication of Cough
    • Authors: Surujpal Teelucksingh; Sateesh Sakhamuri
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Surujpal Teelucksingh, Sateesh Sakhamuri


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.09.032
       
  • Isolated Polyarteritis Nodosa Presenting as Bilateral Testicular Swelling
    • Authors: Subir Bhatia; Loren P. Herrera Hernandez; Amrit K. Kamboj; Katie M. Rieck
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Subir Bhatia, Loren P. Herrera Hernandez, Amrit K. Kamboj, Katie M. Rieck


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.08.040
       
  • Mucocutaneous Secondary Syphilis: ‘The Great Imitator’
    • Authors: Pirabu Sakthivel; Aanchal Kakkar; Suresh Chandra Sharma; Smriti Panda
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Pirabu Sakthivel, Aanchal Kakkar, Suresh Chandra Sharma, Smriti Panda


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.017
       
  • Potentially Reversible Rapid-Onset Weakness: Recognizing Colchicine
           Toxicity
    • Authors: Jacqueline A. Pettersen; Anurag Singh
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Jacqueline A. Pettersen, Anurag Singh


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.08.029
       
  • Polypharmacy: What About Undertreated Medication-Induced
           Hypothyroidism'
    • Authors: Salvatore Benvenga
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Salvatore Benvenga


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.08.035
       
  • Wisely Choosing: Aging, Precision, and Medicine
    • Authors: Larry A. Weinrauch; Ebrahim Barkoudah
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Larry A. Weinrauch, Ebrahim Barkoudah


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.010
       
  • Impact of Observation Hospitalizations on Low-Income Medicare
           Beneficiaries
    • Authors: Ann M. Sheehy; Leslie Thompson; Bradley Flansbaum
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Ann M. Sheehy, Leslie Thompson, Bradley Flansbaum


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.08.034
       
  • Migraine Headache and Long-Term Cardiovascular Outcomes: Methodological
           Issues
    • Authors: Erfan Ayubi; Saeid Safiri
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Erfan Ayubi, Saeid Safiri


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.06.033
       
  • Evaluation of the Yale New Haven Readmission Risk Score for Pneumonia in a
           General Hospital Population: Methodologic Issues
    • Authors: Erfan Ayubi; Saeid Safiri
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Erfan Ayubi, Saeid Safiri


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.08.023
       
  • Hepatocellular Carcinoma Screening in Patients Treated for Hepatitis C
    • Authors: Harsh N. Patel; Jason R. Stibbe; Meghana Vellanki; Harold Paul
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Harsh N. Patel, Jason R. Stibbe, Meghana Vellanki, Harold Paul


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.09.036
       
  • Are You Planning to Sign Up for a Trip to Mars' Extreme Environmental
           Health Consequences of Space Travel
    • Authors: Joseph S. Alpert
      Pages: 115 - 116
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Joseph S. Alpert


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.004
       
  • Implications of Medicare's Value-Based Payment Initiative for Specialty
           Health Systems
    • Authors: Michael Hochman; Jehni Robinson; Kiran Dhanireddy
      Pages: 117 - 118
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Michael Hochman, Jehni Robinson, Kiran Dhanireddy


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.015
       
  • Remembering Corrado Vassanelli
    • Authors: Flavio Ribichini
      First page: 119
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Flavio Ribichini


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.09.020
       
  • A Window to the Brain: Neuro-Ophthalmology for the Primary Care
           Practitioner
    • Authors: Sashank Prasad
      Pages: 120 - 128
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Sashank Prasad
      Visual symptoms, including acute monocular visual loss, papilledema, visual field deficits, anisocoria, limitations of eye movements, and nystagmus, can be the presenting feature of a wide range of important neurologic diseases. It is important for primary care clinicians to be to be able to direct appropriate initial diagnostic assessment, treatment, and referral for further evaluation of these conditions.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.008
       
  • Artificial Intelligence in Medical Practice: The Question to the
           Answer'
    • Authors: D. Douglas Miller; Eric W. Brown
      Pages: 129 - 133
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): D. Douglas Miller, Eric W. Brown
      Computer science advances and ultra-fast computing speeds find artificial intelligence (AI) broadly benefitting modern society—forecasting weather, recognizing faces, detecting fraud, and deciphering genomics. AI's future role in medical practice remains an unanswered question. Machines (computers) learn to detect patterns not decipherable using biostatistics by processing massive datasets (big data) through layered mathematical models (algorithms). Correcting algorithm mistakes (training) adds to AI predictive model confidence. AI is being successfully applied for image analysis in radiology, pathology, and dermatology, with diagnostic speed exceeding, and accuracy paralleling, medical experts. While diagnostic confidence never reaches 100%, combining machines plus physicians reliably enhances system performance. Cognitive programs are impacting medical practice by applying natural language processing to read the rapidly expanding scientific literature and collate years of diverse electronic medical records. In this and other ways, AI may optimize the care trajectory of chronic disease patients, suggest precision therapies for complex illnesses, reduce medical errors, and improve subject enrollment into clinical trials.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.035
       
  • A New HOPE' Lessons from Heart Outcomes Prevention Evaluation-3
    • Authors: Travis M. Howard; Aakash A. Bavishi; Neil J. Stone
      Pages: 134 - 140
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Travis M. Howard, Aakash A. Bavishi, Neil J. Stone
      Lifestyle modification is the cornerstone of preventing atherosclerotic cardiovascular disease. When this is not sufficient in reducing risk, statin therapy is first line. Heart Outcomes Prevention Evaluation (HOPE-3) was a randomized controlled trial of rosuvastatin versus placebo, which demonstrated a significant net benefit in a lower-risk population without known atherosclerotic cardiovascular disease. There were many novel characteristics about this trial that should not be overlooked. It contained a diverse population and was the first trial to base inclusion solely on easily ascertainable metabolic risk factors. It had high adherence in the statin arm, likely due to several factors, including a run-in phase, close follow-up, and low intolerance of moderate-dose rosuvastatin. Attempting to simulate these could increase adherence among clinic populations. Although HOPE-3 did not demonstrate a significant decrease in cardiovascular events among women, meta-analysis including prior randomized controlled trials still demonstrates significant benefit, supporting prior guidelines for statin therapy in this group. Finally, HOPE-3 provides data that potentially support the legacy effect of statins. Understanding these key points provides additional insight into the benefits of statin therapy.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.012
       
  • Cause for Pause: Obstructive Sleep Apnea
    • Authors: Matthew Glassy; Nayereh Pezeshkian; Yingbo Yang; Uma N. Srivatsa
      Pages: 141 - 143
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Matthew Glassy, Nayereh Pezeshkian, Yingbo Yang, Uma N. Srivatsa


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.007
       
  • On the Palms of His Hands: ACTH-Induced Hyperpigmentation
    • Authors: Skand Shekhar; Pramila Dharmshaktu
      Pages: 144 - 145
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Skand Shekhar, Pramila Dharmshaktu


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.037
       
  • First, Rule Out Cancer: Giant Lipoma
    • Authors: Massimo Ralli; Marco de Vincentiis; Antonio Greco
      Pages: 146 - 147
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Massimo Ralli, Marco de Vincentiis, Antonio Greco


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.09.013
       
  • Aerobic Training Effect on Arterial Stiffness in Metabolic Syndrome
    • Authors: Ieva Slivovskaja; Ligita Ryliskyte; Pranas Serpytis; Rokas Navickas; Jolita Badarienė; Jelena Celutkiene; Roma Puronaite; Kristina Ryliskiene; Alma Cypiene; Egidija Rinkuniene; Vaida Sileikiene; Birute Petrauskiene; Alvydas Juocevicius; Aleksandras Laucevicius
      Pages: 148 - 155
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Ieva Slivovskaja, Ligita Ryliskyte, Pranas Serpytis, Rokas Navickas, Jolita Badarienė, Jelena Celutkiene, Roma Puronaite, Kristina Ryliskiene, Alma Cypiene, Egidija Rinkuniene, Vaida Sileikiene, Birute Petrauskiene, Alvydas Juocevicius, Aleksandras Laucevicius
      Background Metabolic syndrome, physical inactivity, and central obesity contribute to early vascular aging, which leads to increased risk of cardiovascular disease. This study aimed to assess the effect of heart rate (HR)-targeted aerobic exercise training on the indices of early vascular aging, in particular, arterial stiffness, and on anthropometric and clinical profile of metabolic syndrome subjects. Methods There were 126 metabolic syndrome subjects randomly selected. Anthropometric parameters, blood pressure (BP), blood sample, and arterial wall functional and structural parameters were obtained prior to and after the 8-week (84 patients) supervised training program. The age- and sex-matched control group (42 patients) followed the same protocol, except for the HR-targeted training program. Results In the study group, HR-targeted training was associated with decreased aortic pulse wave velocity (8.47 ± 1.40 vs 8.01 ± 1.06 m/s; P = .005), HR (P < .001), systolic (P < .015) and diastolic (P < .004) BP, waist circumference (P < .004), total and low-density-lipid cholesterol (respectively, 6.42 ± 1.41 vs 5.89 ± 1.32, P = .003 and 4.2 ± 1.18 vs 3.8 ± 1.21, P = .002), and an increase in aerobic capacity (P < .001). In the control group there were no statistically significant changes of arterial stiffness parameters. Multivariate analysis revealed that reduction of arterial stiffness was BP dependent. Conclusions In subjects with metabolic syndrome, HR-targeted exercise training is associated with BP-dependent decrease in aortic stiffness and improvement of metabolic and fitness parameters.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.07.038
       
  • Infection and Malignancy Outweigh Cardiovascular Mortality in Kidney
           Transplant Recipients: Post Hoc Analysis of the FAVORIT Trial
    • Authors: Larry A. Weinrauch; John A. D'Elia; Matthew R. Weir; Suphamai Bunnapradist; Peter V. Finn; Jiankang Liu; Brian Claggett; Anthony P. Monaco
      Pages: 165 - 172
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Larry A. Weinrauch, John A. D'Elia, Matthew R. Weir, Suphamai Bunnapradist, Peter V. Finn, Jiankang Liu, Brian Claggett, Anthony P. Monaco
      Objective Now that long-term survival after successful renal transplantation is no longer limited by excessive cardiovascular risk, the primary care physician should consider that infection and malignancy are leading noncardiovascular causes of death even in the recipient with diabetes. Methods We accessed the National Institutes of Health–sponsored Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) study population (4010 renal transplant recipients with elevated homocysteine levels) studied to determine whether folate and B12 supplementation would reduce cardiovascular end points. This trial had a null result. Patients were classified as being nondiabetic or having type 1 or type 2 diabetes. Results We report an excess (cardiovascular and noncardiovascular) 6-year mortality risk associated with the presence of diabetes mellitus. Two thirds of fatal events in our renal transplant recipients were centrally adjudicated as noncardiovascular. The incidence of noncardiovascular death was 70% higher in the diabetic patient cohort than in the nondiabetic cohort. Conclusions These results demonstrate that infection (but not malignancy) risks are far higher in diabetic than nondiabetic immunosuppressed individuals (although noncardiovascular death rate in nondiabetic individuals also exceeded cardiovascular deaths) and may play a larger role in the excess mortality populations than previously thought. Given that follow-up in this study was 4 to 10 years after allograft surgery, there was a lesser degree of acute rejection requiring high-dose immunosuppression than in the initial postallograft years. This unique perspective allows transplant recipients to return to primary physicians when taking low doses of immunosuppressive agents and provides focus for follow-up care.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.08.038
       
  • Acute Myocardial Infarction and Stress Cardiomyopathy Are Not Mutually
           Exclusive
    • Authors: Iliana S. Hurtado Rendón; Diego Alcivar; Juan Pablo Rodriguez-Escudero; Kevin Silver
      Pages: 202 - 205
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Iliana S. Hurtado Rendón, Diego Alcivar, Juan Pablo Rodriguez-Escudero, Kevin Silver
      Background Stress cardiomyopathy is a transient cardiac syndrome characterized by reversible left ventricular systolic dysfunction precipitated by emotional or physiologic stress. The presence of obstructive coronary artery disease has been noted in stress cardiomyopathy. Methods We describe 3 case reports of patients with acute coronary syndrome and transient wall motion abnormalities not usually seen in the distribution of coronary artery disease. Results In these 3 cases of acute myocardial infarction, the distribution of the culprit coronary occlusion was not concordant with the territory of transient wall motion abnormality. Follow-up demonstrated resolution of the wall motion abnormalities without intervention in these territories. Conclusion We believe that the physiologic stress of the acute coronary syndrome may have precipitated the stress cardiomyopathy as presented by these patients. This is the first demonstration that stress cardiomyopathy may be precipitated by acute coronary syndrome.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.07.039
       
  • Challenges of Assessing Therapeutic or Diagnostic Outcomes with
           Observational Data
    • Authors: William S. Weintraub; Robert W. Yeh
      Pages: 206 - 210
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): William S. Weintraub, Robert W. Yeh


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.10.027
       
  • Identification of Fabry Disease in a Tertiary Referral Cohort of Patients
           with Hypertrophic Cardiomyopathy
    • Authors: Martin S. Maron; Winnie Xin; Katherine B. Sims; Rita Butler; Tammy S. Haas; Ethan J. Rowin; Robert J. Desnick; Barry J. Maron
      Pages: 200.e1 - 200.e8
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Martin S. Maron, Winnie Xin, Katherine B. Sims, Rita Butler, Tammy S. Haas, Ethan J. Rowin, Robert J. Desnick, Barry J. Maron
      Background Fabry disease is an X-linked lysosomal storage disorder caused by the deficient activity of α-galactosidase A due to mutations in the GLA gene, which may be associated with increased left ventricular wall thickness and mimic the morphologic features of hypertrophic cardiomyopathy. Management strategies for these 2 diseases diverge, with Fabry disease–specific treatment utilizing recombinant α-galactosidase A enzyme replacement therapy. Methods We studied a prospectively assembled consecutive cohort of 585 patients (71% male) from 2 hypertrophic cardiomyopathy tertiary referral centers by screening for low α-galactosidase A activity in dried blood spots. Male patients with low α-galactosidase A activity levels and all females were tested for mutations in the GLA gene. Results In 585 patients previously diagnosed with hypertrophic cardiomyopathy, we identified 2 unrelated patients (0.34%), both with the GLA mutation encoding P.N215S, the most common mutation causing later-onset Fabry disease phenotype. These patients were both asymptomatic, a man aged 53 years and a woman aged 69 years, and demonstrated a mild cardiac phenotype with symmetric distribution of left ventricular hypertrophy. After family screening, a total of 27 new Fabry disease patients aged 2-81 years were identified in the 2 families, including 12 individuals who are now receiving enzyme replacement therapy. Conclusions These observations support consideration for routine prospective screening for Fabry disease in all patients without a definitive etiology for left ventriclar hypertrophy. This strategy would likely result, through cascade family testing, in the earlier identification of new Fabry disease–affected males and female heterozygotes who may benefit from monitoring and/or enzyme replacement therapy.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.09.010
       
  • Budesonide Versus Acetazolamide for Prevention of Acute Mountain Sickness
    • Authors: Grant S. Lipman; David Pomeranz; Patrick Burns; Caleb Phillips; Mary Cheffers; Kristina Evans; Carrie Jurkiewicz; Nick Juul; Peter Hackett
      Pages: 200.e9 - 200.e16
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Grant S. Lipman, David Pomeranz, Patrick Burns, Caleb Phillips, Mary Cheffers, Kristina Evans, Carrie Jurkiewicz, Nick Juul, Peter Hackett
      Background Inhaled budesonide has been suggested as a novel prevention for acute mountain sickness. However, efficacy has not been compared with the standard acute mountain sickness prevention medication acetazolamide. Methods This double-blind, randomized, placebo-controlled trial compared inhaled budesonide versus oral acetazolamide versus placebo, starting the morning of ascent from 1240 m (4100 ft) to 3810 m (12,570 ft) over 4 hours. The primary outcome was acute mountain sickness incidence (headache and Lake Louise Questionnaire ≥3 and another symptom). Results A total of 103 participants were enrolled and completed the study; 33 (32%) received budesonide, 35 (34%) acetazolamide, and 35 (34%) placebo. Demographics were not different between the groups (P > .09). Acute mountain sickness prevalence was 73%, with severe acute mountain sickness of 47%. Fewer participants in the acetazolamide group (n = 15, 43%) developed acute mountain sickness compared with both budesonide (n = 24, 73%) (odds ratio [OR] 3.5, 95% confidence interval [CI] 1.3-10.1) and placebo (n = 22, 63%) (OR 0.5, 95% CI 0.2-1.2). Severe acute mountain sickness was reduced with acetazolamide (n = 11, 31%) compared with both budesonide (n = 18, 55%) (OR 2.6, 95% CI 1-7.2) and placebo (n = 19, 54%) (OR 0.4, 95% CI 0.1-1), with a number needed to treat of 4. Conclusion Budesonide was ineffective for the prevention of acute mountain sickness, and acetazolamide was preventive of severe acute mountain sickness taken just before rapid ascent.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.05.034
       
  • Is 30-Day Mortality after Admission for Heart Failure an Appropriate
           Metric for Quality'
    • Authors: Robert T. Faillace; Gregory W. Yost; Yashasvi Chugh; Jeffrey Adams; Beni R. Verma; Zaid Said; Ibrahim Ismail Sayed; Ashley Honushefsky; Sanjay Doddamani; Peter B. Berger
      Pages: 201.e9 - 201.e15
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Robert T. Faillace, Gregory W. Yost, Yashasvi Chugh, Jeffrey Adams, Beni R. Verma, Zaid Said, Ibrahim Ismail Sayed, Ashley Honushefsky, Sanjay Doddamani, Peter B. Berger
      Background The Centers for Medicare and Medicaid Services (CMS) model for publicly reporting national 30-day-risk-adjusted mortality rates for patients admitted with heart failure fails to include clinical variables known to impact total mortality or take into consideration the culture of end-of-life care. We sought to determine if those variables were related to the 30-day mortality of heart failure patients at Geisinger Medical Center. Methods Electronic records were searched for patients with a diagnosis of heart failure who died from any cause during hospitalization or within 30 days of admission. Results There were 646 heart-failure-related admissions among 530 patients (1.2 admissions/patient). Sixty-seven of the 530 (13%) patients died: 35 (52%) died during their hospitalization and 32 (48%) died after discharge but within 30 days of admission; of these, 27 (40%) had been transferred in for higher-acuity care. Fifty-one (76%) died from heart failure, and 16 (24%) from other causes. Fifty-five (82%) patients were classified as American Heart Association Stage D, 58 (87%) as New York Heart Association Class IV, and 30 (45%) had right-ventricular systolic dysfunction. None of the 32 patients who died after discharge met recommendations for beta-blockers. Criteria for prescribing angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and mineralocorticoid receptor blockers were not met by 33 of the 34 patients (97%) with heart failure with reduced ejection fraction not on one of those drugs. Fifty-seven patients (85%) had a do-not-resuscitate (DNR) status. Conclusion A majority of heart failure-related mortality was among patients who opted for a DNR status with end-stage heart failure, limiting the appropriateness of administering evidence-based therapies. No care gaps were identified that contributed to mortality at our institution. The CMS 30-day model fails to take important variables into consideration.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.09.007
       
  • Social Determinants of Treatment Response
    • Authors: Catherine Bachur; Burton Singer; Allison Hayes-Conroy; Ralph I. Horwitz
      Abstract: Publication date: Available online 5 February 2018
      Source:The American Journal of Medicine
      Author(s): Catherine Bachur, Burton Singer, Allison Hayes-Conroy, Ralph I. Horwitz
      Socioeconomic status is consistently linked to population health, and specifically to the finding that there is decreasing health associated with decreasing social position. Despite this substantial literature, an analogous literature that is focused on clinical practice, and especially consideration of the individual, is almost non-existent. Even in the absence of these data, physicians routinely incorporate patient's life experience (biography) into their estimation of a patient's clinical trajectory (prognosis) and in making therapeutic decisions. Some advances have occurred that strengthen the evidence base such as the Food And Drug Administration decision to show all results from Randomized Controlled Trials on newly approved drugs by age, sex and race. In this paper we review the current status of research on the impact of social determinants of treatment response and illustrate the important role of the therapeutic context in both research and practice. Examples are provided where a patient's “biography” alters treatment response in subgroups of the population studied. We also provide examples where multi-omic data and biographical information in a single individual can illuminate the clinical expression of disease. Finally, we suggest a research agenda that would better support physician's who use social and behavioral features as important elements in their decision-making in clinical care.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2018.01.019
       
  • Cervical Cancer Screening: What's New' Updates for the Busy Clinician
    • Authors: Salina Zhang; Megan McNamara; Pelin Batur
      Abstract: Publication date: Available online 3 February 2018
      Source:The American Journal of Medicine
      Author(s): Salina Zhang, Megan McNamara, Pelin Batur
      In the United States, 12,000 women are diagnosed with cervical cancer each year, even though the screening for this disease is safe and effective. There are 3 types of screening options available: cervical cytology (“Pap” test), Pap/HPV (human papillomavirus) co-test, and HPV (human papillomavirus)-only test. With simplified options such as HPV (human papillomavirus) -only screening, providers who have been reluctant to incorporate cervical cancer screening into their primary care practice may feel more comfortable with offering these services to women. In this review article, we review the different cervical cancer screening options that are now available, and summarize the various changes in guidelines over the last decade.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2018.01.020
       
  • Best Practices for Physician-Scientist Training Programs: Recommendations
           From the Alliance for Academic Internal Medicine
    • Authors: Melvin Blanchard; M. Caroline Burton; Mark W. Geraci; Michael P. Madaio; James D. Marsh; Aaron Proweller; Don C. Rockey; Robert A. Salata; Christopher S. Williams; John Williams; Winston Tan; Mone Zaidi; Robert F. Todd
      Abstract: Publication date: Available online 2 February 2018
      Source:The American Journal of Medicine
      Author(s): Melvin Blanchard, M. Caroline Burton, Mark W. Geraci, Michael P. Madaio, James D. Marsh, Aaron Proweller, Don C. Rockey, Robert A. Salata, Christopher S. Williams, John Williams, Winston Tan, Mone Zaidi, Robert F. Todd


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2018.01.015
       
  • Approach to Peripheral Neuropathy for the Primary Care Clinician
    • Authors: Christopher T. Doughty; Reza Sadjadi
      Abstract: Publication date: Available online 2 February 2018
      Source:The American Journal of Medicine
      Author(s): Christopher T. Doughty, Reza Sadjadi
      Peripheral neuropathy is commonly encountered in the primary care setting and is associated with significant morbidity, including neuropathic pain, falls, and disability. The clinical presentation of neuropathy is diverse, with possible symptoms including weakness, sensory abnormalities, and autonomic dysfunction. Accordingly, the primary care clinician must be comfortable using the neurologic examination—including assessment of motor function, multiple sensory modalities, and the deep tendon reflexes—to recognize and characterize neuropathy. Although the causes of peripheral neuropathy are numerous and diverse, careful review of the medical and family history coupled with limited, select laboratory testing can often efficiently lead to an etiologic diagnosis. This review offers an approach for evaluating suspected neuropathy in the primary care setting. It will describe the most common causes, suggest an evidence-based work-up to aid in diagnosis, and highlight recent evidence that allows for selection of symptomatic treatment of patients with neuropathy.

      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.12.042
       
  • Diagnostic Dilemma
    • Authors: Thomas J. Marrie; Burke A. Cunha; Karishma Chawla
      Abstract: Publication date: Available online 2 February 2018
      Source:The American Journal of Medicine
      Author(s): Thomas J. Marrie, Burke A. Cunha, Karishma Chawla


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2018.01.006
       
  • Elongated Mitral Valve Vegetation
    • Authors: Leonard Riley; Jorge Lascano; Ali Ataya
      Abstract: Publication date: Available online 2 February 2018
      Source:The American Journal of Medicine
      Author(s): Leonard Riley, Jorge Lascano, Ali Ataya


      PubDate: 2018-02-05T11:59:37Z
      DOI: 10.1016/j.amjmed.2017.12.040
       
  • Reply
    • Authors: Lucas Morin
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Lucas Morin


      PubDate: 2018-02-05T11:59:37Z
       
  • The Reply
    • Authors: Jennifer Goldstein; Zugui Zhang Sanford Schwartz LeRoi Hicks
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Jennifer N. Goldstein, Zugui Zhang, J. Sanford Schwartz, LeRoi S. Hicks


      PubDate: 2018-02-05T11:59:37Z
       
  • The Reply
    • Authors: Cecil Rambarat; Islam Elgendy Carl Pepine
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Cecil A. Rambarat, Islam Y. Elgendy, Carl J. Pepine


      PubDate: 2018-02-05T11:59:37Z
       
  • The Reply
    • Authors: Gregory Seymann; Robert El-Kareh Gabrielle Schaefer Jennifer Quartarolo
      Abstract: Publication date: February 2018
      Source:The American Journal of Medicine, Volume 131, Issue 2
      Author(s): Gregory Seymann, Robert El-Kareh, Gabrielle Schaefer, Jennifer Quartarolo


      PubDate: 2018-02-05T11:59:37Z
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.90.119.59
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-